In-depth analysis, data-driven reports, and expert perspectives across the industries driving transformation in the UAE and GCC.

Julphar was founded in Ras Al Khaimah in 1980 as the UAE's first pharmaceutical plant. It reports about 3,000 products made across 16 facilities and sold in more than 50 markets, built the Middle East's first insulin plant in 2012, and recorded AED 1.08 billion of FY2025 revenue.

Fakeeh Care Group was founded in Jeddah in 1978 by Dr Soliman Fakeeh and is now led by the second generation. It runs four hospitals and five medical centres with 835 licensed beds and 439 outpatient clinics, opened a 350-bed university hospital in Dubai Silicon Oasis, and served 1.91 million patients in the year to June 2026.

Dr Sulaiman Al Habib, a consultant paediatrician who had headed his department at Security Forces Hospital in Riyadh, registered a clinics company with SAR 100,000 in 1993 and opened Olaya Medical Complex on King Fahd Road in 1995. The group now runs 22 facilities in Saudi Arabia and Dubai with more than 4,000 beds and over 5,900 physicians, treated 9.46 million patients in 2025, and wrote the hospital information system its sites run on.

Saudi German Health was founded in Jeddah in 1988 and reports 14 hospitals across Saudi Arabia, the UAE, Egypt and Yemen. Its Saudi business runs eight hospitals in seven cities with about 1,800 licensed beds, 7,800 staff and SAR 3.1 billion of 2025 revenue, and holds Magnet, ICHOM and JCI Stroke accreditations.
Thumbay Group was founded in Ajman in 1997 and operates Gulf Medical University, with about 5,000 students, alongside seven to eight UAE hospitals with about 810 beds, 46 pharmacies and 26 brands. It reports 19 million patients treated and a stated group valuation of USD 2.6 billion.

Mediclinic Middle East began with an eight-bed clinic on Hamdan Street, Abu Dhabi, in 1985 and now runs six hospitals and more than 29 clinics across four locations, with about 900 inpatient beds, more than 7,700 staff and AED 5.6 billion of FY2026 revenue.

M42 is described everywhere as Mubadala-backed. Mubadala owns 45 percent. Behind the ownership misread sits the real asset: the Abu Dhabi health information exchange that every licensed facility in the emirate is required to connect to.

Pure Health's IPO got 483× oversubscribed. Then the stock fell 60%. In between, they tripled revenue, bought the UK's biggest private hospital chain, and bought out the Mayo Clinic. The most misunderstood healthcare story in the Gulf.

The rise, hidden-debt fraud collapse, and administration-to-rebuild arc of NMC Health — once the UAE's largest private healthcare operator and a FTSE 100 member.

How Abu Dhabi's Burjeel Holdings — the super-specialty hospital group founded by Dr. Shamsheer Vayalil — turned post-IPO share-price pressure into an operating-leverage comeback across its UAE hospital network.

From a single Dubai clinic in 1987 to a USD 1.65 billion integrated healthcare network. The playbook behind one of the UAE’s most recognised neighbourhood healthcare brands.

A Zavis Research data report comparing healthcare pricing across the UAE's two largest emirates — from GP visits to MRI scans, insurance copays to out-of-pocket costs.

98.7% of UAE residents have health insurance. But having insurance doesn't mean having access. An investigation into what your plan actually covers — and what it quietly excludes.

Inside the 13,772 healthcare facilities and 99,520 licensed professionals powering the UAE's $22 billion healthcare system. The most comprehensive provider distribution analysis ever published.

43% of UAE private clinic patients don't return after their first visit. Clinics spend AED 450 acquiring them. An investigation into the retention economics that most operators are ignoring.

87% of UAE residents use WhatsApp daily. 62% of clinics still book by phone. An investigation into the communication gap costing UAE private healthcare AED millions annually.

A comparative analysis of AI diagnostic liability frameworks in UAE vs USA healthcare, examining who bears responsibility when clinical AI makes errors.

Despite billions invested in healthcare AI, the average doctor consultation remains dangerously short. An investigation into why technology alone isn't enough.

How American health technology companies are establishing major operations across the UAE, and what it means for healthcare sovereignty and innovation.

Discover how artificial intelligence is revolutionizing healthcare delivery, diagnostics, and patient outcomes across the UAE.

Strategic insights into patient acquisition, retention, and service excellence for aesthetic clinics.

Qatar 2025 explores how the country's National Vision 2030 and Digital Agenda are accelerating AI adoption.
Zavis Research publishes original, data-driven reports covering healthcare, hospitality, fintech, retail, and real estate across the UAE and GCC. Our research helps decision-makers understand market dynamics, technology adoption, and emerging opportunities in the region.
Each report combines proprietary analysis with industry data to deliver actionable intelligence for executives, investors, and practitioners.
Learn more about Zavis